Letters to the Editor Related to papers previously published in Cancer. Letters must be submitted within three months of the online publication date of the article discussed in order to be considered. The authors of the original publication will be given the opportunity to respond in the same issue of Cancer. Letters and responses must not exceed 750 words in length and should not have tables or figures.
Letters to the Editor. Letters to the Editor should consist of one or two paragraphs totaling no more than 500 words no abstract no subheadings and fewer than 8 references (one author et al. no titles). If an abstract is included it will automatically be made the first paragraph. Letters should not include figures or research material.
2018-4-11 · Cancer Science- Submission template for Cover letter (If applicable) Tables or Figures from Another Resource If tables or figures have been reproduced from another source a letter from the copyright holder (usually the Publisher) stating authorization to reproduce the material must be attached to the covering letter. (If applicable)
General guidelines for submitting Letters to the Editor/Editorials. A clear title. Do not include an introduction or abstract. Main body of text (excluding tables/figures and references) not to exceed 1 200 words. Maximum of 2 tables or figures allowed. Maximum of 15 references allowed.
These submission are limited to 1000 words and 2 display items (figures/tables) and a maximum of 10 references. Letters to the Editor. Letters should comment on work published in The Oncologist within the previous three months and should contain fewer than 500 words. Letters may be edited for clarity.
Keep lettering consistently sized throughout your final-sized artwork usually about 2–3 mm (8–12 pt). Variance of type size within an illustration should be minimal e.g. do not use 8-pt type on an axis and 20-pt type for the axis label. Avoid effects such as shading outline letters etc.
Manuscript Submission Guidelines for Cancer Informatics. This Journal is a member of the Committee on Publication Ethics.. This Journal recommends that authors follow the Recommendations for the Conduct Reporting Editing and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Recent Cancer Letters Articles. Recently published articles from Cancer Letters. Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy
You might find that the submission system for your chosen journal requires your cover letter to be submitted into a text box rather than as a separate document but it is still a good idea to write a draft first to make sure you have included everything. Always make sure to check the journal IFAs for any specific additional information to include.
2020-4-9 · 8 9oncogene/cancer letter/Theranostics . oncogene/cancer letter/Theranostics. 55 8. 8. 2020-07-28 silent111. 1.0
Dear CancerLetter Submission. Elephants and Tea is proud to introduce our first annual "Dear Cancer" campaign Starting March 1st we are taking submissions for our June 2021 magazine issue that will be all letters to cancer. We want people to speak from their heart and be completely honest in their writing.
2021-3-24 · This community is not edited and does not necessarily reflect the views of Nature Portfolio. Nature Portfolio makes no representations warranties or guarantees whether express or implied that the content on this community is accurate complete or up to date and to the fullest extent permitted by law all liability is excluded.
You might find that the submission system for your chosen journal requires your cover letter to be submitted into a text box rather than as a separate document but it is still a good idea to write a draft first to make sure you have included everything. Always make sure to check the journal IFAs for any specific additional information to include.
present a title that includes if appropriate the study design e.g. "A versus B in the treatment of C a randomized controlled trial" "X is a risk factor for Y a case control study" "What is the impact of factor X on subject Y A systematic review". or for non-clinical or non-research studies a
These submission are limited to 1000 words and 2 display items (figures/tables) and a maximum of 10 references. Letters to the Editor. Letters should comment on work published in The Oncologist within the previous three months and should contain fewer than 500 words. Letters may be edited for clarity.
Scope. Supportive Care in Cancer publishes papers devoted to medical technical and surgical topics as they relate to supportive therapy and care that supplements or substitutes basic cancer treatment at all stages of the disease. The journal focuses on papers and reviews that report on intervention studies and policy-related issues to manage treatment-related toxicities and other supportive
Dear CancerLetter Submission. Elephants and Tea is proud to introduce our first annual "Dear Cancer" campaign Starting March 1st we are taking submissions for our June 2021 magazine issue that will be all letters to cancer. We want people to speak from their heart and be completely honest in their writing.
Letters to the Editor. Letters to the Editor should consist of one or two paragraphs totaling no more than 500 words no abstract no subheadings and fewer than 8 references (one author et al. no titles). If an abstract is included it will automatically be made the first paragraph. Letters should not include figures or research material.
2020-4-9 · 8 9oncogene/cancer letter/Theranostics . oncogene/cancer letter/Theranostics. 55 8. 8. 2020-07-28 silent111. 1.0
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry pharmacology molecular biology genomics and biochemistry of contemporary molecular drug targets involved in cancer e.g. disease specific proteins receptors enzymes and genes.
Scope. Supportive Care in Cancer publishes papers devoted to medical technical and surgical topics as they relate to supportive therapy and care that supplements or substitutes basic cancer treatment at all stages of the disease. The journal focuses on papers and reviews that report on intervention studies and policy-related issues to manage treatment-related toxicities and other supportive
present a title that includes if appropriate the study design e.g. "A versus B in the treatment of C a randomized controlled trial" "X is a risk factor for Y a case control study" "What is the impact of factor X on subject Y A systematic review". or for non-clinical or non-research studies a
2013-12-4 · might include articles on advocacy for funding cancer research government relations training in the field public education or science education. • 2 000 words of text Letters to the Editor In the spirit of open scientific dialogue the Editors invite the submission of correspondence
These submission are limited to 1000 words and 2 display items (figures/tables) and a maximum of 10 references. Letters to the Editor. Letters should comment on work published in The Oncologist within the previous three months and should contain fewer than 500 words. Letters may be edited for clarity.
Letters to the Editor may be edited for clarity or length and may be subject to peer review at the Editors discretion. To contribute please contact the editors. waivers for substantial critiques of articles published in Infectious Agents and Cancer. Where authors are submitting a manuscript that represents a substantial critique of an
Letters to the Editor. Letters to the Editor should consist of one or two paragraphs totaling no more than 500 words no abstract no subheadings and fewer than 8 references (one author et al. no titles). If an abstract is included it will automatically be made the first paragraph. Letters should not include figures or research material.
Keep lettering consistently sized throughout your final-sized artwork usually about 2–3 mm (8–12 pt). Variance of type size within an illustration should be minimal e.g. do not use 8-pt type on an axis and 20-pt type for the axis label. Avoid effects such as shading outline letters etc.
Manuscript Submission. Author membership in the American Society of Hematology is not a prerequisite for submission or publication in Blood and is not taken into consideration during the peer review process.. All manuscripts must be submitted online through eJournalPress. Blood does not accept submissions unless they are made online through this site. If you have not used this website before
Scope. Supportive Care in Cancer publishes papers devoted to medical technical and surgical topics as they relate to supportive therapy and care that supplements or substitutes basic cancer treatment at all stages of the disease. The journal focuses on papers and reviews that report on intervention studies and policy-related issues to manage treatment-related toxicities and other supportive
You might find that the submission system for your chosen journal requires your cover letter to be submitted into a text box rather than as a separate document but it is still a good idea to write a draft first to make sure you have included everything. Always make sure to check the journal IFAs for any specific additional information to include.
Keep lettering consistently sized throughout your final-sized artwork usually about 2–3 mm (8–12 pt). Variance of type size within an illustration should be minimal e.g. do not use 8-pt type on an axis and 20-pt type for the axis label. Avoid effects such as shading outline letters etc.
Average submission to first decision is 17 days. Cancer Science is the official journal of the Japanese Cancer Association. Cancer Science publishes original articles editorials and letters to the editor describing original research in the fields of basic translational and clinical cancer research.
Submission Request to the Guidelines Panels. A Guidelines panel will consider published scientific data for drugs biologics diagnostics procedures or devices used for cancer prevention detection treatment or supportive care within the NCCN Guidelines. Submissions are accepted throughout the year and are triaged to be addressed on an
If you re looking for solid advice on how to write a strong journal submission cover letter that will convince journal editors to review your research paper then look no further We know that cover letters can impact an editor s decision to consider your research paper further. As such this guide aims to explain (1) why you should care
2021-6-14 · Manuscript submission process • Sub-headings and general headings should be presented in lower case letters (not capitals). • Use British English or American English spellings throughout your manuscript but not both. 3.2 Manuscripts The first page should include
General guidelines for submitting Letters to the Editor/Editorials. A clear title. Do not include an introduction or abstract. Main body of text (excluding tables/figures and references) not to exceed 1 200 words. Maximum of 2 tables or figures allowed. Maximum of 15 references allowed.
2013-12-4 · might include articles on advocacy for funding cancer research government relations training in the field public education or science education. • 2 000 words of text Letters to the Editor In the spirit of open scientific dialogue the Editors invite the submission of correspondence
Dear Cancer Letter Submission Elephants and Tea is proud to introduce our first annual "Dear Cancer" campaign Starting March 1st we are taking submissions for our June 2021 magazine issue that will be all letters to cancer. We want people to speak from their heart and be completely honest in their writing.
2021-7-5 · Correlation of the Grade Group of Prostate Cancer according to the International Society of Urological Pathology (Isup) 2014 Classification between Prostate Biopsy and Radical Prostatectomy Specimens. Serkan Akan Caner Ediz M. Cihan Temel Ferhat Ates Omer Yilmaz. Pages 521-528.
2019-11-3 · Information for anyone preparing a submission to Nature Journal. Nature welcomes submissions of Articles Reviews and Perspectives and Matters Arising via the online submission system ease note that we do not accept submissions via email. Before submitting a contribution we recommend you review the essential information for Authors which includes details about the editorial
BQ+ Medical not only produce components for manufacturers all over the world, but also provide private label manufacturing for leading brand distributors in different countries.
8,Cheye Road,Songjiang District,Shanghai 201611 China.
Tel: 86-021-57743953
Email: [email protected]
Copyright © BQ PLUS MEDICAL CO., LTDSitemap | Contact Us |
